Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00962494 · ClinicalTrials.gov registry record · Phase 2
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 585
- Enrollment target
NCT00962494: Completed Phase 2 study, sponsored by Stanford University.
NCT00962494 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 585 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (340% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00962494, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 585 participants
- Enrollment target
Study Summary
Cancer: Surviving and Thriving is a 6-week workshop for cancer survivors. The overall goal of the study is to determine whether an online cancer survivor education and support workshop can have lasting beneficial effects in helping survivors improve their self-management of health skills and quality of life.
Interventions
- BEHAVIORAL Cancer: Thriving and Surviving Online Workshop
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
What the finished NCT00962494 record still lists
NCT00962494 is an interventional study that assigns participants to a tested intervention. The registered 585 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (340% higher).
The record links to 0 conditions, and to 1 intervention - of which Cancer: Thriving and Surviving Online Workshop is the first listed.
NCT00962494 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00962494 about?
NCT00962494 is a clinical study titled "Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors". Cancer: Surviving and Thriving is a 6-week workshop for cancer survivors. The overall goal of the study is to determine whether an online cancer survivor education and support workshop can have lasting beneficial effects in helping survivors improve their self-management of health skills and quality...
What is the current status of trial NCT00962494?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 585 participants. The study started on 2009-07. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00962494?
The interventions under investigation include: Cancer: Thriving and Surviving Online Workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT00962494?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00962494's enrollment target sits among peer trials
585 58th of 2000 higher than 1,943 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02803957 · 585 participants · NA
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
- NCT06680869 · 585 participants · Phase 3
Early Amiodarone in Shockable Cardiac Arrest
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia